| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/2003 | WO2002016603A3 23228, a novel human tetraspanin family member and uses thereof |
| 01/30/2003 | WO2002016550A3 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 01/30/2003 | WO2002014501A3 Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer |
| 01/30/2003 | WO2002014356A3 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 01/30/2003 | WO2002013873A9 P97-active agent conjugates and their methods of use |
| 01/30/2003 | WO2002012285A3 The tumor suppressor car-1 |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002007773A3 Multi-component biological transport systems |
| 01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/30/2003 | WO2002003071A3 Modulators of trk protein activity, compositions and uses |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001094416A3 Human proteins and nucleic acids encoding same |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001081576A3 Novel g protein-coupled receptor con-218 |
| 01/30/2003 | WO2001079293A3 Human cadherin molecules and uses therefor |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001077172A3 Non-endogenous, constitutively activated known g protein-coupled receptors |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | WO2001025273A9 Compositions and methods for wt1 specific immunotherapy |
| 01/30/2003 | US20030023999 Transgenic mice containing GNB1 gene disruptions |
| 01/30/2003 | US20030023996 Nucleotide sequences coding protein for use in the diagnosis and treatment of prostate cancer |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023073 Growth differentiation factor-15 |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023069 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/30/2003 | US20030023068 For diagnosis and therapy |
| 01/30/2003 | US20030023067 Follistatin-related protein zfsta2 |
| 01/30/2003 | US20030023066 For therapy and prophylaxis of Helicobacter infection |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023058 For therapy of cancer |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023048 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023046 Vascular endothelial cell growth factor antagonists |
| 01/30/2003 | US20030023045 Reshaped human antibody to human medulloblastoma cells |
| 01/30/2003 | US20030023044 Human G-Protein chemokine receptor (CCR5) HDGNR10 |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023036 Drugs, vaccines |
| 01/30/2003 | US20030023035 Useful as therapeutic agents and in diagnostics |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030022875 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 01/30/2003 | US20030022870 Methods of treating cardiac disorders |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022857 Mitogen-activated protein (MAP) kinase phosphatase (MKP) for use in metabolic disorders; gene expression; genetic engineering; diagnosis |
| 01/30/2003 | US20030022854 Vaccines using nucleic acid-lipid complexes |
| 01/30/2003 | US20030022853 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 01/30/2003 | US20030022852 Biodegradable immunomodulatory formulations and methods for use thereof |
| 01/30/2003 | US20030022851 Long term memory, synaptic plasticity and the ADF1 transcription factor |
| 01/30/2003 | US20030022848 Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression |
| 01/30/2003 | US20030022842 Orally administering skin care agent comprising an ingestible carrier and natural-type N-acetylglucosamine obtainable by hydrolysis of chitin with an acid, an enzyme, or an acid and an enzyme |
| 01/30/2003 | US20030022841 Growth differentiation factor, Lefty-1 |
| 01/30/2003 | US20030022840 Drugs for ameliorating impaired glucose tolerance |
| 01/30/2003 | US20030022838 Methods for pacifying the surface of a prosthetic biomaterial |
| 01/30/2003 | US20030022836 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 01/30/2003 | US20030022835 Compositions isolated from skin cells and methods for their use |
| 01/30/2003 | US20030022834 Methods and devices for promoting endothelial morphogenesis |
| 01/30/2003 | US20030022833 Inhibiting proliferation of a breast cancer cell which expresses a prolactin receptor, by exposing cell to a variant of human prolactin having a substitution of the glycine at position 129 |
| 01/30/2003 | US20030022831 Compositions employ a delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of compound conjugated to reagent across one or more layers of tissue, compared to non-conjugated compound |
| 01/30/2003 | US20030022830 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 01/30/2003 | US20030022829 Novel antiviral activities primate theta defensins and mammalian cathelicidins |
| 01/30/2003 | US20030022828 A growth factor formulation comprising: a polypeptide of the TGF- beta (tranformation growth factor) superfamily, N-vinyl-2-pyrrolidone polymer carrier and a solvent selected from water and aqueous buffer solutions |
| 01/30/2003 | US20030022826 Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents |
| 01/30/2003 | US20030022825 An isolated polynucleotide encoding a polypeptide having stem cell growth factor activity, said polynucleotide hybridizes to the complement of above polynucleotide under stringent hybridization conditions |
| 01/30/2003 | US20030022824 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022823 Glucagon-like peptide (GLP-1), an analog, or a derivative, is administered at a dose effective to normalize blood glucose after myocardial infarction in diabetic patients |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022821 A modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin seuquence |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022817 A protein hydrolysate to the preparation of a energy supplementation or metabolic nutrient, characterized in, that it is an animal or vegetable protein hydrolysate having a degree of hydrolysis of 1-50 |
| 01/30/2003 | US20030022816 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 01/30/2003 | US20030022374 Modulating photoreactivity in a cell |
| 01/30/2003 | US20030022368 Suppression of differentiation in pluripotent stem cells; obtain stem cells, incubate with suppressor polypetide, monitor cell differentiation |
| 01/30/2003 | US20030022355 Vectors and methods for gene transfer |
| 01/30/2003 | US20030022354 Protein c derivatives |
| 01/30/2003 | US20030022353 Protein for use in the treatment of nervous system disorders |
| 01/30/2003 | US20030022352 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein |
| 01/30/2003 | US20030022350 Enzymatic polypeptide for use in the prevention of thrombosis |
| 01/30/2003 | US20030022340 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022329 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and cell proliferation disorders |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022327 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022326 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022314 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 01/30/2003 | US20030022313 Novel neuronal cell growth factor |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022311 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022306 Polypeptide for use in the treatment of cancer |
| 01/30/2003 | US20030022302 Toll-like receptor |
| 01/30/2003 | US20030022299 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022292 Ligation of CEACAM1 |
| 01/30/2003 | US20030022286 Novel transporter-like genes and uses therefor |